Misdiagnosis of multisystem inflammatory syndrome in children: A diagnostic challenge

As the COVID‐19 pandemic continues, multisystem inflammatory syndrome in children (MIS‐C) maintains its importance in the differential diagnosis of common febrile diseases. MIS‐C should be promptly diagnosed because corticosteroid and/or intravenous immunoglobulin treatment can prevent severe clinical outcomes. In this study, we aimed to evaluate clinical presentation, diagnostic parameters and management of MIS‐C and compare its clinical features to those of common febrile disease.

[1]  A. Moreira,et al.  Multisystem inflammatory syndrome (MIS-C): a systematic review and meta-analysis of clinical characteristics, treatment, and outcomes , 2021, Jornal de pediatria.

[2]  M. Waseem,et al.  Multisystem Inflammatory Syndrome in Children , 2021, The Journal of Emergency Medicine.

[3]  Jeffrey I. Campbell,et al.  Differentiating multisystem inflammatory syndrome in children: a single-centre retrospective cohort study , 2021, Archives of Disease in Childhood.

[4]  J. Newburger,et al.  Mistaken MIS-C: A Case Series of Bacterial Enteritis Mimicking MIS-C. , 2021, The Pediatric infectious disease journal.

[5]  B. Santiago-García,et al.  Severe Foodborne Bacterial Infections Mimicking Multisystem Inflammatory Syndrome in Children Associated With COVID-19. , 2021, The Pediatric Infectious Disease Journal.

[6]  B. Cummings,et al.  Distinguishing Features of Patients Evaluated for Multisystem Inflammatory Syndrome in Children , 2021, Pediatric emergency care.

[7]  E. Liu,et al.  Multisystem inflammatory syndrome in children during the coronavirus disease 2019 (COVID-19) pandemic: a systematic review of published case studies , 2020, Translational pediatrics.

[8]  T. Kuno,et al.  COVID‐19 and multisystem inflammatory syndrome in children: A systematic review and meta‐analysis , 2020, Pediatric pulmonology.

[9]  Jeffrey I. Campbell,et al.  NON-SARS-CoV-2 INFECTIONS AMONG PATIENTS EVALUATED FOR MIS-C ASSOCIATED WITH COVID-19. , 2020, The Pediatric infectious disease journal.

[10]  P. Zachariah,et al.  Discriminating Multisystem Inflammatory Syndrome in Children Requiring Treatment from Common Febrile Conditions in Outpatient Settings , 2020, The Journal of Pediatrics.

[11]  P. Soler-Palacín,et al.  Multi-Inflammatory Syndrome in Children related to SARS-CoV-2 in Spain , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  Michael Levin,et al.  Childhood Multisystem Inflammatory Syndrome — A New Challenge in the Pandemic , 2020, The New England journal of medicine.

[13]  Simon Li,et al.  Multisystem Inflammatory Syndrome in U.S. Children and Adolescents , 2020, The New England journal of medicine.

[14]  P. Davies,et al.  Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. , 2020, JAMA.

[15]  P. Zachariah,et al.  Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City. , 2020, JAMA.

[16]  Christopher Earl,et al.  Preexisting and de novo humoral immunity to SARS-CoV-2 in humans , 2020, Science.

[17]  Angelo Mazza,et al.  An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study , 2020, The Lancet.

[18]  P. Theocharis,et al.  Hyperinflammatory shock in children during COVID-19 pandemic , 2020, The Lancet.

[19]  Jérémie F. Cohen,et al.  Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study , 2020, BMJ.

[20]  Multisystem in fl ammatory syndrome in children associated with COVID-19 in 101 cases from Turkey (Turk-MISC study) , 2022 .